Eriksson study epidemiology, genes and the environment - Eriksson

What type of article is Eriksson (2007), and what does it examine?

A narrative review (secondary source) that discusses findings from the Helsinki Birth Cohort Study and other research to explain how early growth and gene–environment interactions influence adult disease risk.

How was the Helsinki Birth Cohort Study used to investigate different health outcomes?

Researchers used the same birth cohort to investigate different early-life exposures:

• Evacuation research: Examined how childhood separation and stress during WWII related to mental health in adulthood and offspring.

• Eriksson (2007): Reviewed how fetal growth, childhood BMI changes, and gene–environment interactions related to adult Coronary heart disease CHD and type 2 diabetes.

What is the main finding discussed in Eriksson's reading?

Poor fetal and infant growth, especially when followed by rapid childhood weight gain, is associated with a greater risk of CHD and type 2 diabetes in adulthood.

How does fetal growth influence the risk of coronary heart disease (CHD)?

Babies born small or thin have a higher risk of developing CHD later in life, mainly due to restricted fetal growth rather than premature birth.

What factors and measurements are associated with restricted fetal growth?

Maternal or fetal undernutrition can contribute to restricted growth. Signs include low birth weight, short birth length, and low ponderal index (low weight relative to length).

Can fetal programming occur without restricted growth at birth?

Yes! Findings from the Dutch Hunger Winter suggest that poor prenatal conditions can cause lasting developmental changes, even without obvious growth restriction at birth.

How does poor infant growth affect the risk of CHD?

Low weight at age 1 is an independent predictor of CHD. The highest risk occurs when poor fetal growth is followed by poor infant growth.

What other health-related finding was associated with low weight at age 1?

Low weight at age 1 was associated with an atherogenic lipid profile, meaning blood lipid levels that increase the risk of plaque buildup in arteries.

What childhood growth pattern was associated with the highest CHD risk?

Small/thin at birth → Poor infant growth → Rapid weight and BMI gain after age 5 → Increased CHD risk.

Does higher childhood BMI increase CHD risk equally for all children?

No. Higher childhood BMI was particularly associated with CHD among children who were small or thin at birth.

Why is growth trajectory important when studying CHD risk?

Because CHD risk depends on a person's growth pattern from fetal life through childhood, not just their birth weight or childhood BMI alone.

What early-life growth pattern was associated with increased type 2 diabetes risk?

Small/thin at birth → Thin infancy → Early BMI rebound → Rapid later BMI gain → Increased type 2 diabetes risk.

: How are the early growth patterns associated with CHD and type 2 diabetes similar?

Both are associated with small birth size, poor early growth, and rapid childhood weight or BMI gain.

How do the growth patterns associated with obesity and type 2 diabetes differ?

• Obesity: Often larger at birth and continues growing larger.

• Type 2 diabetes: Often smaller at birth, followed by faster BMI gain later in childhood.

What is BMI rebound, and when does it normally occur?

BMI rebound is when a child's BMI stops decreasing and begins increasing again, usually around ages 5–6.

How does the timing of BMI rebound influence type 2 diabetes risk?

Earlier BMI rebound is associated with higher diabetes risk.

• Before age 5: 8.6% developed type 2 diabetes.

• After age 7: 1.8% developed type 2 diabetes.

What is the relationship between birth weight and type 2 diabetes risk?

A possible U-shaped relationship, meaning both very low and very high birth weights may be associated with increased type 2 diabetes risk.

fetal insulin hypothesis

the same genetic factors may contribute to both poor fetal growth and impaired glucose regulation later in life.

Can one gene explain the relationship between small birth size and adult disease?

No. Evidence suggests that genes and early-life environmental conditions interact to influence adult disease risk.

What is the function of PPAR genes?

They help regulate glucose, lipid, and energy metabolism.

How do the PPAR-γ2 Pro12Pro and Pro12Ala genotypes differ?

• Pro12Pro: Associated with greater insulin resistance following small birth size.

• Pro12Ala (Ala allele): Associated with better insulin sensitivity and lower type 2 diabetes risk.

How did PPAR-γ2 demonstrate a gene–environment interaction?

Small birth size was associated with insulin resistance mainly in people with the Pro12Pro genotype, while those carrying the protective Ala allele showed a weaker or absent association.

What is the PC-1 121Q variant associated with?

The 121Q allele is associated with insulin resistance.

How did birth size affect disease risk among people with the PC-1 121Q allele?

People carrying the 121Q allele had higher rates of type 2 diabetes and hypertension, mainly when they were also small at birth.

What do the PPAR-γ2 and PC-1 findings demonstrate?

They demonstrate gene–environment interactions, where genetic risk for metabolic disease depends partly on early-life growth conditions.

How does Eriksson's reading support the DOHaD concept?

It shows that conditions during fetal development and early childhood can influence the risk of chronic diseases in adulthood, including CHD and type 2 diabetes.

What is the main conclusion of Eriksson's review?

Adult disease risk depends on the entire pattern of growth from fetal life through childhood, along with interactions between genes and the early environment.